Rain Therapeutics Inc (RAIN)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
CEO:
Avanish Vellanki
Employees:
8000 JARVIS AVENUE, SUITE 204, NEWARK, CA 94560
(510) 953-5559

We are a clinical-stage precision oncology company developing therapies that target oncogenic drivers for which we are able to genetically select patients we believe will most likely benefit. This approach includes using a tumor-agnostic strategy to select patients based on their tumors’ underlying genetics rather than histology. Our corporate offices are located at 8000 Jarvis Avenue, Suite 204, Newark, California.

Data derived from most recent annual or quarterly report
Market Cap 99.149 Million Shares Outstanding26.51 Million Avg 30-day Volume 411.869 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.39
Price to Revenue0.0 Debt to Equity0.0 EBITDA-61.962 Million
Price to Book Value1.1752 Operating Margin0.0 Enterprise Value11.333 Million
Current Ratio9.723 EPS Growth0.814 Quick Ratio9.443
1 Yr BETA 1.7772 52-week High/Low 22.22 / 2.15 Profit Margin0.0
Operating Cash Flow Growth-265.3046 Altman Z-Score4.3428 Free Cash Flow to Firm -37.251 Million
Earnings Report2022-08-09

View recent insider trading info

Rain Therapeutics Inc YCharts
Yahoo! Finance finviz

Funds Holding RAIN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding RAIN BETA

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

25 Thousand total shares from 1 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

VELLANKI AVANISH CHAIRMAN AND CEO

  • Officer
  • Director
  • 10% Owner
 2,471,627 2022-06-01 4

DOEBELE ROBERT SEE REMARKS

  • Officer
 481,827 2022-04-13 3

BRYCE RICHARD PAUL CHIEF MEDICAL OFFICER

  • Officer
 53,064 2022-01-07 1

CABATUAN NELSON SEE REMARKS

  • Officer
 32,000 2022-01-07 1

BVF PARTNERS L P/IL

BIOTECHNOLOGY VALUE FUND L P

BVF I GP LLC

BIOTECHNOLOGY VALUE FUND II LP

BVF II GP LLC

BIOTECHNOLOGY VALUE TRADING FUND OS LP

BVF PARTNERS OS LTD.

BVF GP HOLDINGS LLC

BVF INC/IL

LAMPERT MARK N

  • Director
  • 10% Owner
  • SEE REMARKSSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSES
8,008,205 2022-01-06 4

PERCEPTIVE ADVISORS LLC

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD

EDELMAN JOSEPH

  • 10% Owner
 2,487,019 2021-10-07 1

BERGER FRANKLIN M

  • Director
 840,326 2021-09-21 1

WOLFF STEFANI

  • Director
 24,000 2021-05-14 0

CORMORANT ASSET MANAGEMENT, LP

CHEN BIHUA

CORMORANT GLOBAL HEALTHCARE MASTER FUND, LP

CORMORANT PRIVATE HEALTHCARE FUND III LP

CORMORANT PRIVATE HEALTHCARE FUND II, LP

  • Director
  • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
 No longer subject to file 2021-04-27 0

RADOVICH PETER

  • Director
 8,796 2021-04-27 0

BOXER CAPITAL, LLC

BOXER ASSET MANAGEMENT INC.

LEWIS JOSEPH

  • Director
  • 10% Owner
 4,277,215 2021-04-23 0

DAVIS AARON I.

MVA INVESTORS, LLC

  • Director
  • 10% Owner
 4,277,215 2021-04-23 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

VELLANKI AVANISH - Director - Officer - > 10% Owner CHAIRMAN AND CEO

2022-06-02 16:05:41 -0400 2022-06-01 P 25,000 $2.29 a 2,471,627 direct -7.4074 -7.4074 7.037 4 -7.4074 2

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
RAIN THERAPEUTICS INC RAIN 2022-06-24 22:15:03 UTC -23.8781 25.4481 20000
RAIN THERAPEUTICS INC RAIN 2022-06-24 21:45:03 UTC -23.8781 25.4481 20000
RAIN THERAPEUTICS INC RAIN 2022-06-24 21:15:04 UTC -23.8781 25.4481 20000
RAIN THERAPEUTICS INC RAIN 2022-06-24 20:45:03 UTC -23.8781 25.4481 15000
RAIN THERAPEUTICS INC RAIN 2022-06-24 20:15:03 UTC -23.8781 25.4481 15000
RAIN THERAPEUTICS INC RAIN 2022-06-24 19:45:03 UTC -23.8781 25.4481 15000
RAIN THERAPEUTICS INC RAIN 2022-06-24 19:15:03 UTC -23.8781 25.4481 15000
RAIN THERAPEUTICS INC RAIN 2022-06-24 18:45:03 UTC -23.8781 25.4481 15000
RAIN THERAPEUTICS INC RAIN 2022-06-24 18:15:04 UTC -23.8781 25.4481 15000
RAIN THERAPEUTICS INC RAIN 2022-06-24 17:45:03 UTC -23.8781 25.4481 15000
RAIN THERAPEUTICS INC RAIN 2022-06-24 17:15:03 UTC -23.8781 25.4481 15000
RAIN THERAPEUTICS INC RAIN 2022-06-24 16:45:03 UTC -22.1051 23.6751 15000
RAIN THERAPEUTICS INC RAIN 2022-06-24 16:15:03 UTC -22.1051 23.6751 15000
RAIN THERAPEUTICS INC RAIN 2022-06-24 15:45:03 UTC -22.1051 23.6751 9000
RAIN THERAPEUTICS INC RAIN 2022-06-24 15:15:03 UTC -22.1051 23.6751 3000
RAIN THERAPEUTICS INC RAIN 2022-06-24 14:45:03 UTC -19.8826 21.4526 3000
RAIN THERAPEUTICS INC RAIN 2022-06-24 14:15:03 UTC -19.8826 21.4526 2000
RAIN THERAPEUTICS INC RAIN 2022-06-24 13:45:03 UTC -19.8826 21.4526 2000
RAIN THERAPEUTICS INC RAIN 2022-06-24 13:15:03 UTC -19.8826 21.4526 3000
RAIN THERAPEUTICS INC RAIN 2022-06-23 15:45:03 UTC -19.8826 21.4526 700

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments